Susan E Manley1, Kathleen T O'Brien2, Diarmuid Quinlan3, Rachel A Round4, Peter G Nightingale5, Fauzi Ali2, Behram K Durrani6, Aaron Liew7, Stephen D Luzio8, Irene M Stratton9, Graham A Roberts10. 1. Diabetes Translational Research Group, Institute of Translational Medicine, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK; Division of Medical Sciences, University of Birmingham, Birmingham, UK. Electronic address: susan.manley@uhb.nhs.uk. 2. Waterford Institute of Technology, Waterford, Ireland. 3. Department of General Practice, University College Cork, Cork, Ireland. 4. Diabetes Translational Research Group, Institute of Translational Medicine, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK. 5. Wellcome Trust Clinical Research Facility, Institute of Translational Medicine, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK. 6. Department of Endocrinology and Diabetes, University Hospital Waterford, Waterford, Ireland. 7. Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK; Portiuncula Hospital and Galway University Hospital, Galway, Ireland; National University of Ireland, (NUIG), Galway, Ireland. 8. Diabetes Research Group, Swansea University, Swansea, UK. 9. Gloucester Retinopathy Research Group, Gloucestershire Hospitals NHS Foundation Trust, Cheltenham, UK. 10. Waterford Institute of Technology, Waterford, Ireland; Department of Endocrinology and Diabetes, University Hospital Waterford, Waterford, Ireland; School of Medicine, University College Cork, Cork, Ireland; Department of Epidemiology & Public Health, University College Cork, Cork, Ireland; College of Medicine, Swansea University, Swansea, UK.
Abstract
OBJECTIVE: To study hyperglycaemia in acute medical admissions to Irish regional hospital. RESEARCH DESIGN AND METHODS: From 2005 to 2007, 2061 white Caucasians, aged >18 years, were admitted by 1/7 physicians. Those with diabetes symptoms/complications but no previous record of hyperglycaemia (n=390), underwent OGTT with concurrent HbA1c in representative subgroup (n=148). Comparable data were obtained for 108 primary care patients at risk of diabetes. RESULTS: Diabetes was diagnosed immediately by routine practice in 1% (22/2061) [aged 36 (26-61) years (median IQ range)/55% (12/22) male] with pre-existing diabetes/dysglycaemia present in 19% (390/2061) [69 (58-80) years/60% (235/390) male]. Possible diabetes symptoms/complications were identified in 19% [70 (59-79) years/57% (223/390) male] with their HbA1c similar to primary care patients [54 (46-61) years], 5.7 (5.3-6.0)%/39 (34-42)mmol/mol (n=148) vs 5.7 (5.4-6.1)%/39 (36-43)mmol/mol, p=0.35, but lower than those diagnosed on admission, 10.2 (7.4-13.3)%/88 (57-122)mmol/mol, p<0.001. Their fasting plasma glucose (FPG) was similar to primary care patients, 5.2 (4.8-5.7) vs 5.2 (4.8-5.9) mmol/L, p=0.65, but 2hPG higher, 9.0 (7.3-11.4) vs 5.5 (4.4-7.5), p<0.001. HbA1c identified diabetes in 10% (15/148) with 14 confirmed on OGTT but overall 32% (48/148) were in diabetic range on OGTT. The specificity of HbA1c in 2061 admissions was similar to primary care, 99% vs 96%, p=0.20, but sensitivity lower, 38% vs 93%, p<0.001 (63% on FPG/23% on 2hPG, p=0.037, in those with possible symptoms/complications). CONCLUSION: HbA1c can play a diagnostic role in acute medicine as it diagnosed another 2% of admissions with diabetes but the discrepancy in sensitivity shows that it does not reflect transient/acute hyperglycaemia resulting from the acute medical event.
OBJECTIVE: To study hyperglycaemia in acute medical admissions to Irish regional hospital. RESEARCH DESIGN AND METHODS: From 2005 to 2007, 2061 white Caucasians, aged >18 years, were admitted by 1/7 physicians. Those with diabetes symptoms/complications but no previous record of hyperglycaemia (n=390), underwent OGTT with concurrent HbA1c in representative subgroup (n=148). Comparable data were obtained for 108 primary care patients at risk of diabetes. RESULTS:Diabetes was diagnosed immediately by routine practice in 1% (22/2061) [aged 36 (26-61) years (median IQ range)/55% (12/22) male] with pre-existing diabetes/dysglycaemia present in 19% (390/2061) [69 (58-80) years/60% (235/390) male]. Possible diabetes symptoms/complications were identified in 19% [70 (59-79) years/57% (223/390) male] with their HbA1c similar to primary care patients [54 (46-61) years], 5.7 (5.3-6.0)%/39 (34-42)mmol/mol (n=148) vs 5.7 (5.4-6.1)%/39 (36-43)mmol/mol, p=0.35, but lower than those diagnosed on admission, 10.2 (7.4-13.3)%/88 (57-122)mmol/mol, p<0.001. Their fasting plasma glucose (FPG) was similar to primary care patients, 5.2 (4.8-5.7) vs 5.2 (4.8-5.9) mmol/L, p=0.65, but 2hPG higher, 9.0 (7.3-11.4) vs 5.5 (4.4-7.5), p<0.001. HbA1c identified diabetes in 10% (15/148) with 14 confirmed on OGTT but overall 32% (48/148) were in diabetic range on OGTT. The specificity of HbA1c in 2061 admissions was similar to primary care, 99% vs 96%, p=0.20, but sensitivity lower, 38% vs 93%, p<0.001 (63% on FPG/23% on 2hPG, p=0.037, in those with possible symptoms/complications). CONCLUSION: HbA1c can play a diagnostic role in acute medicine as it diagnosed another 2% of admissions with diabetes but the discrepancy in sensitivity shows that it does not reflect transient/acute hyperglycaemia resulting from the acute medical event.
Authors: Sandip Ghosh; Susan E Manley; Peter G Nightingale; John A Williams; Radhika Susarla; Irene Alonso-Perez; Irene M Stratton; Georgios V Gkoutos; Jonathan Webber; Stephen D Luzio; Wasim Hanif; Graham A Roberts Journal: Endocrinol Diabetes Metab Date: 2020-05-15
Authors: D Bhattacharjee; S Vracar; R A Round; P G Nightingale; J A Williams; G V Gkoutos; I M Stratton; R Parker; S D Luzio; J Webber; S E Manley; G A Roberts; S Ghosh Journal: Diabet Med Date: 2019-04-30 Impact factor: 4.359
Authors: Andrew J Farmer; Brian Shine; Laura C Armitage; Noel Murphy; Tim James; Nishan Guha; Rustam Rea Journal: Diabet Med Date: 2022-07-26 Impact factor: 4.213